These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 24836064

  • 1. Tamiphosphor monoesters as effective anti-influenza agents.
    Chen CL, Lin TC, Wang SY, Shie JJ, Tsai KC, Cheng YS, Jan JT, Lin CJ, Fang JM, Wong CH.
    Eur J Med Chem; 2014 Jun 23; 81():106-18. PubMed ID: 24836064
    [Abstract] [Full Text] [Related]

  • 2. Kinetic, thermodynamic and structural analysis of tamiphosphor binding to neuraminidase of H1N1 (2009) pandemic influenza.
    Albiñana CB, Machara A, Řezáčová P, Pachl P, Konvalinka J, Kožíšek M.
    Eur J Med Chem; 2016 Oct 04; 121():100-109. PubMed ID: 27236066
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.
    Xie Y, Xu D, Huang B, Ma X, Qi W, Shi F, Liu X, Zhang Y, Xu W.
    J Med Chem; 2014 Oct 23; 57(20):8445-58. PubMed ID: 25255388
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir.
    Bantia S, Parker CD, Ananth SL, Horn LL, Andries K, Chand P, Kotian PL, Dehghani A, El-Kattan Y, Lin T, Hutchison TL, Montgomery JA, Kellog DL, Babu YS.
    Antimicrob Agents Chemother; 2001 Apr 23; 45(4):1162-7. PubMed ID: 11257030
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors.
    Li Z, Meng Y, Xu S, Shen W, Meng Z, Wang Z, Ding G, Huang W, Xiao W, Xu J.
    Bioorg Med Chem; 2017 May 15; 25(10):2772-2781. PubMed ID: 28385598
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Discovery of novel "Dual-site" binding oseltamivir derivatives as potent influenza virus neuraminidase inhibitors.
    Ai W, Zhang J, Zalloum WA, Jia R, Cherukupalli S, Ding X, Sun Z, Sun L, Jiang X, Ma X, Li Z, Wang D, Huang B, Zhan P, Liu X.
    Eur J Med Chem; 2020 Apr 01; 191():112147. PubMed ID: 32092589
    [Abstract] [Full Text] [Related]

  • 15. Divalent oseltamivir analogues as potent influenza neuraminidase inhibitors.
    Yan ZL, Liu AY, Wei XX, Zhang Z, Qin L, Yu Q, Yu P, Lu K, Yang Y.
    Carbohydr Res; 2019 May 15; 477():32-38. PubMed ID: 30954773
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Development of novel potent orally bioavailable oseltamivir derivatives active against resistant influenza A.
    Schade D, Kotthaus J, Riebling L, Kotthaus J, Müller-Fielitz H, Raasch W, Koch O, Seidel N, Schmidtke M, Clement B.
    J Med Chem; 2014 Feb 13; 57(3):759-69. PubMed ID: 24422530
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.